Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adolfo López de Munain

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Medicina Clinica|April 22, 2008
[DNA arrays: a general overview and specific applications]Amets Sáenz, Adolfo López de Munain
Expert Reviews in Molecular Medicine|June 20, 2015
Costamere proteins and their involvement in myopathic processesOihane Jaka, Leire Casas-Fraile, Adolfo López de Munain, et al.
Expert Reviews in Molecular Medicine|October 9, 2014
Dysregulation of calcium homeostasis in muscular dystrophiesAinara Vallejo-Illarramendi, Ivan Toral-Ojeda, Garazi Aldanondo, et al.
Journal of Neuropsychology|August 14, 2019
Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up studyGarazi Labayru, Jone Aliri, Miren Zulaica, et al.
Neuromuscular Disorders : NMD|November 15, 2023
Executive functions and daily functioning in myotonic dystrophy type 1 ecological assessment with virtual realityJoana Garmendia, Garazi Labayru, Jone Aliri, et al.
Frontiers in Neurology|May 24, 2024
CNS involvement in myotonic dystrophy type 1: does sex play a role?Joana Garmendia, Garazi Labayru, Jone Aliri, et al.
International Journal of Molecular Sciences|March 10, 2022
Targeting Myotonic Dystrophy Type 1 with MetforminMikel García-Puga, Ander Saenz-Antoñanzas, Ander Matheu, et al.
Vision Research|October 2, 2012
Current mutation discovery approaches in Retinitis PigmentosaAnder Anasagasti, Cristina Irigoyen, Olatz Barandika, et al.
Annals of Human Genetics|December 3, 2014
Neurogenetic disorders in the Basque populationJosé Félix Martí Massó, Juan José Zarranz, David Otaegui, et al.
European Journal of Neurology|October 18, 2022
Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow-up studyJoana Garmendia, Garazi Labayru, Miren Zulaica, et al.
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Medicina Clinica|April 22, 2008
[DNA arrays: a general overview and specific applications]Amets Sáenz, Adolfo López de Munain
Expert Reviews in Molecular Medicine|June 20, 2015
Costamere proteins and their involvement in myopathic processesOihane Jaka, Leire Casas-Fraile, Adolfo López de Munain, et al.
Expert Reviews in Molecular Medicine|October 9, 2014
Dysregulation of calcium homeostasis in muscular dystrophiesAinara Vallejo-Illarramendi, Ivan Toral-Ojeda, Garazi Aldanondo, et al.
Journal of Neuropsychology|August 14, 2019
Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up studyGarazi Labayru, Jone Aliri, Miren Zulaica, et al.
Neuromuscular Disorders : NMD|November 15, 2023
Executive functions and daily functioning in myotonic dystrophy type 1 ecological assessment with virtual realityJoana Garmendia, Garazi Labayru, Jone Aliri, et al.
Frontiers in Neurology|May 24, 2024
CNS involvement in myotonic dystrophy type 1: does sex play a role?Joana Garmendia, Garazi Labayru, Jone Aliri, et al.
International Journal of Molecular Sciences|March 10, 2022
Targeting Myotonic Dystrophy Type 1 with MetforminMikel García-Puga, Ander Saenz-Antoñanzas, Ander Matheu, et al.
Vision Research|October 2, 2012
Current mutation discovery approaches in Retinitis PigmentosaAnder Anasagasti, Cristina Irigoyen, Olatz Barandika, et al.
Annals of Human Genetics|December 3, 2014
Neurogenetic disorders in the Basque populationJosé Félix Martí Massó, Juan José Zarranz, David Otaegui, et al.
European Journal of Neurology|October 18, 2022
Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow-up studyJoana Garmendia, Garazi Labayru, Miren Zulaica, et al.
Pageof 19